Key points
- Verdict: yes, a good choice.
- Idli is steamed, low in fat and easy on the stomach, at roughly 50 to 60 calories each.
- Have 2 or 3 idlis with a large bowl of sambar.
- On GLP-1 medicines: Idli is one of the gentlest foods on days you feel queasy on GLP-1 medicines.
Our dietitians' verdict
Yes, a good choice
Idli nutrition
| Per 1 medium idli, about 40 g | |
|---|---|
| Calories | about 55 each |
| Protein | about 2 g each |
| Carbohydrate | about 11 g each |
| Fibre | under 1 g each |
| Fat | almost none |
Approximate values from the Indian Food Composition Tables (ICMR-NIN, 2017) and USDA FoodData Central. Recipes and brands vary.
How idli can help
- Steamed, so almost no added oil.
- Fermentation makes it easy to digest.
- Sambar adds dal protein and vegetables.
What to watch
- Idlis are mostly rice, so 5 or 6 at a time add up.
- Coconut chutney and ghee or podi with oil add a lot of calories.
- Idli alone is low in protein.
The best way to eat idli for weight loss
- Have 2 or 3 idlis with a large bowl of sambar.
- Try ragi, oats or moong dal idlis for more fibre and protein.
- Choose tomato or mint chutney more often than coconut chutney.
On Mounjaro or semaglutide?
Idli is one of the gentlest foods on days you feel queasy on GLP-1 medicines. Add sambar or a side of curd so you still get protein. See our guide to eating on GLP-1 treatment.
Questions
How many idlis can I eat for weight loss?
2 to 3 with sambar is a good breakfast for most people.
Is idli or dosa better for weight loss?
Idli, usually, because it's steamed rather than cooked with oil.
Is idli good for diabetes?
In small portions with sambar, yes for many people. Ragi or moong idlis raise blood sugar less than plain rice idlis.
References
- Longvah T et al. Indian Food Composition Tables 2017. ICMR-National Institute of Nutrition
- ICMR-National Institute of Nutrition. Nutrient requirements for Indians: recommended dietary allowances and estimated average requirements, 2020 (brief note)
- Mozaffarian D et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint advisory from the American College of Lifestyle Medicine, American Society for Nutrition, Obesity Medicine Association and The Obesity Society. 2025




